Zanaflex News
Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriters - Business Wire (press release)
The Company’s marketed products include Zanaflex Capsules ® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ...
Acorda Therapeutics' 4Q Loss Widens - CNNMoney.com
Revenue rose 45 percent to $11.2 million from $7.7 million, benefiting from gross sales of its anti-muscle spasm drug Zanaflex totaling $12.8 million. ...
Acorda reports Q4 loss - Business in the Burbs
Acorda markets Zanaflex, a treatment for involuntary muscle movements caused by multiple sclerosis and spinal injuries. ...
Earnings roundup: Loews, Napco - Forbes
... Therapeutics Inc. said Monday its fourth-quarter loss widened on higher operating expenses, but sales of its drug Zanaflex helped drive revenue higher. ...
Acorda Therapeutics Q4 Loss Widens On Expenses [ACOR] - RTT News
The company reported gross sales of Zanaflex Capsules of $11.8 million and gross sales of Zanaflex of $1.0 million, providing combined gross sales of $12.8 ...
Earnings roundup: Loews, Napco - CNNMoney.com
... Inc. (NASDAQ:ACOR) said Monday its fourth-quarter loss widened on higher operating expenses, but sales of its drug Zanaflex helped drive revenue higher. ...
Acorda Therapeutics Reports Fourth Quarter and Full Year 2007 ... - Business Wire (press release)
For the fourth quarter ended December 31, 2007, the Company reported gross sales of Zanaflex Capsules (tizanidine hydrochloride) of $11.8 million and gross ...
Earnings roundup: Loews, Napco - Forbes
... Therapeutics Inc. said Monday its fourth-quarter loss widened on higher operating expenses, but sales of its drug Zanaflex helped drive revenue higher. ...
Acorda Therapeutics, Inc. Announces Pricing of Public Offering of ... - FOXBusiness
The Company's marketed products include Zanaflex Capsules(R) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ...
Earnings roundup: Loews, Napco - Forbes
... Therapeutics Inc. said Monday its fourth-quarter loss widened on higher operating expenses, but sales of its drug Zanaflex helped drive revenue higher. ...
Zanaflex RSS Feed